Authors:
SHARIATMADAR Z
MAHDI F
ROJKJAER R
SCHMAIER AH
Citation: Z. Shariatmadar et al., MAPPING KININOGENS BINDING DOMAIN ON HUMAN ENDOTHELIAL-CELL CYTOKERATIN-1, Journal of investigative medicine, 46(3), 1998, pp. 233-233
Citation: R. Rojkjaer et al., A REVISED HYPOTHESIS FOR CONTACT SYSTEM ACTIVATION ON ENDOTHELIAL-CELLS - FACTOR-XII IS NOT THE PRIMARY ACTIVATOR, Journal of investigative medicine, 46(3), 1998, pp. 233-233
Authors:
ROJKJAER R
HASAN AAK
MOTTA G
SCHOUSBOE I
SCHMAIER AH
Citation: R. Rojkjaer et al., FACTOR-XII DOES NOT INITIATE PREKALLIKREIN ACTIVATION ON ENDOTHELIAL-CELLS, Thrombosis and haemostasis, 80(1), 1998, pp. 74-81
Authors:
MUSIAL J
GLUSZKO P
UNDAS A
MAHDI F
KANG S
SZCZEKLIK A
SCHMAIER AH
Citation: J. Musial et al., GAMMA-INTERFERON ADMINISTRATION TO PATIENTS WITH ATOPIC-DERMATITIS INHIBITS FIBRINOLYSIS AND ELEVATES C1 INHIBITOR, Thrombosis research, 89(6), 1998, pp. 253-261
Citation: Aak. Hasan et al., IDENTIFICATION OF CYTOKERATIN-1 AS A BINDING-PROTEIN AND PRESENTATIONRECEPTOR FOR KININOGENS ON ENDOTHELIAL-CELLS, Proceedings of the National Academy of Sciences of the United Statesof America, 95(7), 1998, pp. 3615-3620
Authors:
ANNICH G
WHITE T
DAMM D
ZHAO YQ
FAKHRI M
MEINHARDT J
REBELLO S
LUCCHESI BR
BARTLETT RH
SCHMAIER AH
Citation: G. Annich et al., RECOMBINANT KUNITZ PROTEASE INHIBITOR DOMAIN OF THE AMYLOID BETA-PROTEIN PRECURSOR AS AN ANTICOAGULANT FOR EXTRACORPOREAL-CIRCULATION IN RABBITS, Circulation, 98(17), 1998, pp. 3817-3817
Authors:
HASAN AAK
KRISHNAN R
TULINSKY A
SUJATA S
SCHMAIER AH
Citation: Aak. Hasan et al., THE MECHANISM OF THROMBOSTATINS INHIBITION OF THROMBIN-INDUCED PLATELET ACTIVATION, Circulation, 98(17), 1998, pp. 4195-4195
Authors:
MOTTA G
ROJKJAER R
HASAN AAK
CINES DB
SCHMAIER AH
Citation: G. Motta et al., HIGH-MOLECULAR-WEIGHT KININOGEN REGULATES PREKALLIKREIN ASSEMBLY AND ACTIVATION ON ENDOTHELIAL-CELLS - A NOVEL MECHANISM FOR CONTACT ACTIVATION, Blood, 91(2), 1998, pp. 516-528
Citation: Rw. Colman et Ah. Schmaier, CONTACT SYSTEM - A VASCULAR BIOLOGY MODULATOR WITH ANTICOAGULANT, PROFIBRINOLYTIC, ANTIADHESIVE, AND PROINFLAMMATORY ATTRIBUTES, Blood, 90(10), 1997, pp. 3819-3843
Authors:
PIPE SW
SCHMAIER AH
NICHOLS WC
GINSBURG D
BOZYNSKI MEA
CASTLE VP
Citation: Sw. Pipe et al., NEONATAL PURPURA FULMINANS IN ASSOCIATION WITH FACTOR-V R506Q MUTATION, The Journal of pediatrics, 128(5), 1996, pp. 706-709
Citation: Aak. Hasan et al., BRADYKININ AND ITS METABOLITE, ARG-PRO-PRO-GLY - PHE, ARE SELECTIVE INHIBITORS OF ALPHA-THROMBIN-INDUCED PLATELET ACTIVATION, Circulation, 94(3), 1996, pp. 517-528
Citation: Aak. Hasan et al., CONFORMATIONAL-CHANGES IN LOW-MOLECULAR-WEIGHT KININOGEN ALTERS ITS ABILITY TO BIND TO ENDOTHELIAL-CELLS, Thrombosis and haemostasis, 74(4), 1995, pp. 1088-1095
Citation: Aak. Hasan et al., BRADYKININ AND RELATED PEPTIDES SELECTIVELY INHIBIT ALPHA-THROMBINS ABILITY TO ACTIVATE THE PLATELET THROMBIN RECEPTOR, Thrombosis and haemostasis, 73(6), 1995, pp. 924-924